📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell-mediated toxicity against glioblastoma. (2022)

First Author: Ma R

Attributed to: Cutaneous Immunology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/neuonc/noac107

PubMed Identifier: 35468205

Publication URI: http://europepmc.org/abstract/MED/35468205

Type: Journal Article/Review

Volume: 24

Parent Publication: Neuro-oncology

Issue: 12

ISSN: 1522-8517